Patents by Inventor Richard L. Verrier

Richard L. Verrier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230146182
    Abstract: An implantable vagus nerve stimulation (VNS) system includes a sensor configured to measure ECG data for a patient, a stimulation subsystem configured to deliver VNS to the patient, and a control system configured to perform a heart rate variability analysis with the ECG data. In some aspects, performing the heart rate variability analysis includes measuring R-R intervals between successive R-waves for the ECG data measured during a stimulation period of VNS therapy and a baseline period of the VNS therapy, wherein the stimulation period comprises at least a portion of the ON period and the baseline period comprises at least a portion of the OFF period immediately preceding the ON period, and generating a plot of each R-R interval against an immediately successive R-R interval for each of the stimulation period and the baseline period configured to be displayed on a display.
    Type: Application
    Filed: January 3, 2023
    Publication date: May 11, 2023
    Applicant: LivaNova USA, Inc.
    Inventors: Imad Libbus, Bruce D. Nearing, Badri Amurthur, Bruce H. KenKnight, Richard L. Verrier
  • Patent number: 11554263
    Abstract: An implantable vagus nerve stimulation (VNS) system includes a sensor configured to measure ECG data for a patient, a stimulation subsystem configured to deliver VNS to the patient, and a control system configured to perform a heart rate variability analysis with the ECG data. In some aspects, performing the heart rate variability analysis includes measuring R-R intervals between successive R-waves for the ECG data measured during a stimulation period and a baseline period, plotting each R-R interval against an immediately preceding R-R interval for each of the stimulation period and the baseline period, and determining at least one of a standard deviation from an axis of a line perpendicular to an identity line for each of the stimulation period plot and the baseline period plot or a centroid of each of the stimulation period plot and the baseline period plot.
    Type: Grant
    Filed: May 24, 2019
    Date of Patent: January 17, 2023
    Assignee: LivaNova USA, Inc.
    Inventors: Imad Libbus, Bruce D. Nearing, Badri Amurthur, Bruce H. KenKnight, Richard L. Verrier
  • Publication number: 20220218260
    Abstract: Disclosed herein are example methods and systems for predicting efficacy of pacemakers or cardiac resynchronization therapy (CRT) devices prior to implantation in patients based on electrocardiogram (ECG) heterogeneity analysis. A method of determining or predicting efficacy of implanting a pacemaker or cardiac resynchronization therapy (CRT) device in a patient includes receiving a first set of electrocardiogram (ECG) signals associated with the patients heart from spatially separated leads, analyzing data from the first set of ECG signals, quantifying a spatio-temporal heterogeneity of the first set of ECG signals based on the analysis, and determining or predicting efficacy of implanting the pacemaker or cardiac re-synchronization therapy (CRT) device in the patient based on the quantified spatio-temporal heterogeneity.
    Type: Application
    Filed: May 7, 2020
    Publication date: July 14, 2022
    Applicant: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Richard L. VERRIER, Bruce D. Nearing, Peter J. ZIMETBAUM
  • Publication number: 20210059551
    Abstract: A method and system for high-throughput detection of coronary artery stenosis observes trends in abnormal or pathologic morphology of the electrocardiogram (ECG). A first set of ECG signals is monitored from a patient. A baseline measurement is generated from the monitored first set of ECG signals to contain nonpathologic ECG morphologies in each lead. A second set of ECG signals is monitored from the patient and a second mean measurement during or after stress is generated from the second set of ECG signals. A residuum signal is generated for each lead based on the baseline measurement and the second mean measurement. The residuum signals are averaged across the leads for each timepoint. T-wave heterogeneity is quantified based on the generated residuum signals and the averaged residuum signal at each timepoint, and used to detect coronary artery stenosis.
    Type: Application
    Filed: March 8, 2019
    Publication date: March 4, 2021
    Applicant: Beth Israel Deaconess Medical Center,
    Inventors: Bruce D. NEARING, Richard L. VERRIER
  • Publication number: 20190358456
    Abstract: An implantable vagus nerve stimulation (VNS) system includes a sensor configured to measure ECG data for a patient, a stimulation subsystem configured to deliver VNS to the patient, and a control system configured to perform a heart rate variability analysis with the ECG data. In some aspects, performing the heart rate variability analysis includes measuring R-R intervals between successive R-waves for the ECG data measured during a stimulation period and a baseline period, plotting each R-R interval against an immediately preceding R-R interval for each of the stimulation period and the baseline period, and determining at least one of a standard deviation from an axis of a line perpendicular to an identity line for each of the stimulation period plot and the baseline period plot or a centroid of each of the stimulation period plot and the baseline period plot.
    Type: Application
    Filed: May 24, 2019
    Publication date: November 28, 2019
    Inventors: Imad Libbus, Bruce D. Nearing, Badri Amurthur, Bruce H. KenKnight, Richard L. Verrier
  • Patent number: 10022060
    Abstract: A method and system for high-throughput prediction of the onset of heart arrhythmias observes trends in abnormal or pathologic morphology of the electrocardiogram (ECG). A first set of ECG signals is monitored from a patient. A baseline measurement is generated from the monitored first set of ECG signals to contain nonpathologic ECG morphologies in each lead. A second set of ECG signals is monitored from the patient and a second baseline measurement is generated from the second set of ECG signals. A residuum signal is generated for each lead based on the baseline measurement and the second baseline measurement. The residuum signals are averaged across the leads. R-wave heterogeneity, T-wave heterogeneity, P-wave heterogeneity, or ST-segment heterogeneity or other indicators of arrhythmia risk or myocardial ischemia are quantified based on the generated residuum signals and the averaged residuum signal.
    Type: Grant
    Filed: June 9, 2015
    Date of Patent: July 17, 2018
    Assignee: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Bruce D. Nearing, Richard L. Verrier
  • Publication number: 20150272462
    Abstract: A method and system for high-throughput prediction of the onset of heart arrhythmias observes trends in abnormal or pathologic morphology of the electrocardiogram (ECG). A first set of ECG signals is monitored from a patient. A baseline measurement is generated from the monitored first set of ECG signals to contain nonpathologic ECG morphologies in each lead. A second set of ECG signals is monitored from the patient and a second baseline measurement is generated from the second set of ECG signals. A residuum signal is generated for each lead based on the baseline measurement and the second baseline measurement. The residuum signals are averaged across the leads. R-wave heterogeneity, T-wave heterogeneity, P-wave heterogeneity, or ST-segment heterogeneity or other indicators of arrhythmia risk or myocardial ischemia are quantified based on the generated residuum signals and the averaged residuum signal.
    Type: Application
    Filed: June 9, 2015
    Publication date: October 1, 2015
    Inventors: Bruce D. Nearing, Richard L. Verrier
  • Patent number: 9060699
    Abstract: A method and system for predicting the onset of heart arrhythmias more accurately observes trends in abnormal or pathologic morphology of the electrocardiogram (ECG). A first set of ECG signals is monitored from a patient. A baseline measurement is generated from the monitored first set of ECG signals to contain nonpathologic ECG morphologies in each lead. A second set of ECG signals is monitored from the patient and the baseline measurement is subtracted from the second set of ECG signals on a beat-to-beat basis. Afterwards, a residuum signal is generated for each lead based on the subtraction. R-wave heterogeneity, T-wave heterogeneity, P-wave heterogeneity, or ST-segment heterogeneity or other indicators of arrhythmia risk or myocardial ischemia are quantified based on the generated residuum signals.
    Type: Grant
    Filed: September 21, 2012
    Date of Patent: June 23, 2015
    Assignee: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Bruce D. Nearing, Richard L. Verrier
  • Publication number: 20140088449
    Abstract: A method and system for predicting the onset of heart arrhythmias more accurately observes trends in abnormal or pathologic morphology of the electrocardiogram (ECG). A first set of ECG signals is monitored from a patient. A baseline measurement is generated from the monitored first set of ECG signals to contain nonpathologic ECG morphologies in each lead. A second set of ECG signals is monitored from the patient and the baseline measurement is subtracted from the second set of ECG signals on a beat-to-beat basis. Afterwards, a residuum signal is generated for each lead based on the subtraction. R-wave heterogeneity, T-wave heterogeneity, P-wave heterogeneity, or ST-segment heterogeneity or other indicators of arrhythmia risk or myocardial ischemia are quantified based on the generated residuum signals.
    Type: Application
    Filed: September 21, 2012
    Publication date: March 27, 2014
    Applicant: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Bruce D. NEARING, Richard L. Verrier
  • Publication number: 20040215168
    Abstract: A method and kit for accessing the pericardial space take advantage of the fact that the right auricle is a thin-walled, low-pressure structure which can be readily penetrated without damaging the pericardium or the epicardium. The method includes the step of passing a guide catheter through a selected peripheral vein to establish a transvenous route to the right auricle of the heart. An infusion guide wire and a leading guide wire are passed through the guide catheter and into the right auricle so that a distal end of the leading guide wire is positioned against a wall of the right auricle. The leading guide wire is located within a lumen of the infusion guide wire and protrudes outward, preferably about 2 mm, from a distal end of the infusion guide wire. The wall of the right auricle is then pierced with the distal end of the leading guide wire. After the wall of the right auricle is pierced, at least one of the infusion guide wire and the leading guide wire are advanced into the pericardial space.
    Type: Application
    Filed: January 23, 2004
    Publication date: October 28, 2004
    Applicant: Beth Israel Deaconess Medical Center
    Inventors: Richard L. Verrier, Sergio Waxman
  • Publication number: 20010039410
    Abstract: A method and kit for accessing the pericardial space take advantage of the fact that the right auricle is a thin-walled, low-pressure structure which can be readily penetrated without damaging the pericardium or the epicardium. The method includes the step of passing a guide catheter through a selected peripheral vein to establish a transvenous route to the right auricle of the heart. An infusion guide wire and a leading guide wire are passed through the guide catheter and into the right auricle so that a distal end of the leading guide wire is positioned against a wall of the right auricle. The leading guide wire is located within a lumen of the infusion guide wire and protrudes outward, preferably about 2 mm, from a distal end of the infusion guide wire. The wall of the right auricle is then pierced with the distal end of the leading guide wire. After the wall of the right auricle is pierced, at least one of the infusion guide wire and the leading guide wire are advanced into the pericardial space.
    Type: Application
    Filed: January 26, 2001
    Publication date: November 8, 2001
    Inventors: Richard L. Verrier, Sergio Waxman
  • Patent number: 6169919
    Abstract: A system and method for quantifying alternation in the T-wave and ST segment of an ECG signal receives a digitized ECG signal (i.e., ECG data) for processing. The ECG data are used to calculate an odd median complex for the odd beats in the ECG data and an even median complex for the even beats in the ECG data. The odd median complex and the even median complex are then compared to obtain an estimate of the amplitude of beat-to-beat alternation in the ECG signal. Prior to calculation of the even and odd median complexes, the ECG data are filtered. Filtering of the ECG data involves low pass filtering the ECG data to remove high frequency noise, applying a baseline wander removal filter to the ECG data to remove low frequency artifacts, removing arrhythmic beats from the ECG data, and eliminating noisy beats from the ECG data. The filtered data are more suitable for calculation of an accurate estimate of alternation.
    Type: Grant
    Filed: June 18, 1999
    Date of Patent: January 2, 2001
    Assignee: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Bruce D. Nearing, Richard L. Verrier
  • Patent number: 5968010
    Abstract: A method for placing various types of catheters into the pericardial space takes advantage of the fact that the right auricle is a thin-walled, low-pressure structure which can be readily penetrated without damaging the pericardium or the epicardium. A guide catheter is passed through a selected peripheral vein to establish a transvenous route to the right auricle of the heart. A needle catheter is then passed through the guide catheter and into the right auricle so that a distal end of the needle catheter is positioned against a wall of the right auricle. The wall of the right auricle is then pierced with the needle catheter. A guide wire is advanced through the needle catheter and into the pericardial space. Once in position, the guide wire can be used as a conduit over which a desired catheter may be introduced for performing a specific medical procedure.
    Type: Grant
    Filed: April 30, 1997
    Date of Patent: October 19, 1999
    Assignee: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Sergio Waxman, Richard L. Verrier
  • Patent number: 5921940
    Abstract: The non-invasive, dynamic tracking and diagnosing of cardiac vulnerability to ventricular fibrillation involves analysis of both cardiac electrical stability and the influence of autonomic activity. The magnitude of alternation in an electrocardiogram is indicative of cardiac electrical stability. Alternans are made manifest by applying a physiologic stress such as exercise or behavioral stress to a subject.
    Type: Grant
    Filed: November 4, 1997
    Date of Patent: July 13, 1999
    Assignee: Georgetown University
    Inventors: Richard L. Verrier, Bruce D. Nearing
  • Patent number: 5902250
    Abstract: A method for determining the sleep state of a patient includes monitoring heart rate variability of the patient and determining sleep state based on the heart rate variability. The method also may include monitoring the frequency of eyelid movements and making the sleep state determination based also on the frequency of eyelid movements. A method for determining respiratory pattern includes monitoring heart rate variability by receiving heart beat signals and determining respiratory pattern from the strength of the signals. A home-based, wearable, self-contained system determines sleep-state and respiratory pattern, and assesses cardiorespiratory risk, of a patient based on the frequency of eyelid movements, the frequency of head movements, and heart rate variability of the patient.
    Type: Grant
    Filed: March 31, 1997
    Date of Patent: May 11, 1999
    Assignees: President and Fellows of Harvard College, Beth Israel Deaconess Medical Center, Inc.
    Inventors: Richard L. Verrier, J. Allan Hobson, Eric G. Lovett, Edward F. Pace-Schott
  • Patent number: 5842997
    Abstract: A method and an apparatus for the non-invasive, dynamic tracking and diagnosing of cardiac vulnerability to ventricular fibrillation are disclosed. T-wave alternans and heart rate variability are simultaneously evaluated. T-wave alternation is an absolute predictor of cardiac electrical stability. Heart rate variability is a measure of autonomic influence, a major factor in triggering cardiac arrhythmias. By simultaneously analyzing both phenomena, the extent and cause of cardiac vulnerability can be assessed.
    Type: Grant
    Filed: April 30, 1997
    Date of Patent: December 1, 1998
    Assignee: Georgetown University
    Inventors: Richard L. Verrier, Bruce D. Nearing
  • Patent number: 5560370
    Abstract: A method and apparatus for predicting cardiac electrical instability simultaneously assesses T-Wave Alternans and QT Interval Dispersion. T-wave alternation is an excellent predictor of cardiac electrical instability but can be influenced by mechano-electrical coupling. Thus, a measure of alternation has a high degree of sensitivity but a low degree of specificity. The low specificity of alternation is addressed by simultaneously analyzing QT interval dispersion. Dispersion is not a measure of excitable stimulus and is not sensitive to mechano-electrical coupling. The resulting combination of alternans and dispersion yields an accurate predictor of cardiac electrical instability caused by intrinsic factors.
    Type: Grant
    Filed: May 26, 1995
    Date of Patent: October 1, 1996
    Assignee: Georgetown University
    Inventors: Richard L. Verrier, Bruce D. Nearing
  • Patent number: 5437285
    Abstract: A method and apparatus for predicting susceptibility to sudden cardiac death simultaneously assessing cardiac electrical stability and autonomic influence. Cardiac electrical stability is assessed by analyzing at least one of a beat-to-beat alternation in a T-wave of an ECG of a patient's heart and dispersion of repolarization in the ECG of the patient's heart. Autonomic influence on the patient's heart is assessed by analyzing at least one of a magnitude of heart rate variability in the ECG of the patient's heart and baroreceptor sensitivity.
    Type: Grant
    Filed: November 30, 1993
    Date of Patent: August 1, 1995
    Assignee: Georgetown University
    Inventors: Richard L. Verrier, Bruce D. Nearing
  • Patent number: 5269326
    Abstract: A method for placing various types of catheters into the pericardial space takes advantage of the fact that the right auricle is a thin-walled, low-pressure structure which can be readily penetrated without damaging the pericardium or the epicardium. The method avoids surgical trauma and the risks of general anesthesia and infection. A catheter is guided downstream through one of the venae cavae to the right atrium. Once inside the right atrium, the catheter is passed into the right auricle. The wall at the apex of the right auricle is then pierced to gain access to the pericardial space. The method can be used, for example, to provide electrical stimuli to the heart (e.g., for pacing, cardioversion, and defibrillation), to pick-up an ECG signal, to deliver pharmacologic agents to the heart, to improve vascularization, to remove pericardial fluid for analysis or pericardiocentesis, or to inject a radio-labelled or echo-sensitive dye into the pericardial space for precision fluid imaging.
    Type: Grant
    Filed: October 24, 1991
    Date of Patent: December 14, 1993
    Assignee: Georgetown University
    Inventor: Richard L. Verrier
  • Patent number: 5265617
    Abstract: A method and apparatus for the non-invasive, dynamic tracking and diagnosing of cardiac vulnerability to ventricular fibrillation are disclosed. T-wave alternans and heart rate variability are simultaneously evaluated. T-wave alternation is an absolute predictor of cardiac electrical instability. Heart rate variability is a measure of autonomic influence, a major factor in triggering cardiac arrythmias. By simultaneously analyzing both phenomena, the extent and cause of cardiac vulnerability can be assessed. The method includes the following steps. An ECG signal is sensed from a heart. The T-wave portions of the ECG signal are analyzed to estimate an amplitude of beat-to-beat alternation. The amplitude of beat-to-beat alternation represents cardiac electrical instability. The R-R intervals are analyzed to estimate a magnitude of a high frequency component of heart rate variability and to estimate a magnitude of a low frequency component of heart rate variability.
    Type: Grant
    Filed: September 22, 1992
    Date of Patent: November 30, 1993
    Assignee: Georgetown University
    Inventors: Richard L. Verrier, Bruce D. Nearing